Genesis Research Group is proud to be attending ISPOR Europe 2025 in Glasgow from 10-12th November with a strong scientific ...

Discover how Inizio experts are shaping the future of obesity care—where science, strategy, and innovation unite to advance ...

At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications ...

Pharmaceutical companies can help facilitate patient pathway stakeholder engagement by partnering with patients, providers ...

Medherant, a clinical-stage company developing treatments using a novel transdermal drug delivery technology, has reported ...

GSK has received approval from the US Food and Drug Administration (FDA) for Blenrep (belantamab mafodotin-blmf) in ...

The GPPG is more than a publication – it’s a movement towards truly patient- centric and accessible healthcare. It aims to ...

Doctored Truths” exposes the escalating crisis of health misinformation and disinformation, which has been ranked the world’s ...

Novartis has agreed to acquire Avidity Biosciences, a San Diego-based biopharmaceutical company developing therapies for rare ...

Macmillan Cancer Support and 11 NHS Trusts have jointly published a report highlighting the benefits of prehabilitation ...

The data, first presented at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting, showed that the phase 3 ...

ProImmune, life sciences reagents and services provider, has announced the opening on its new global headquarters building at ...